Scott Dunseth Myers Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Scott Dunseth Myers.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Scott Dunseth Myers. Scott Dunseth Myers is President & CEO in AMAG PHARMACEUTICALS, INC. ($AVM) and Senior Vice President in Euthymics Bioscience Inc ($DOVP) and President and CEO in Oncothyreon Inc. ($ONTY) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in Harpoon Therapeutics, Inc. ($HARP).
Latest Insider Trading Transactions of Scott Dunseth Myers
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVM, CASC, DOVP, HARP, SELB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 07 2021 | HARP | Harpoon Therapeuti ... | Myers Scott Dunseth | Director | Option Exercise | A | 22.50 | 10,167 | 228,758 | 10,167 | |
| Apr 01 2021 | SELB | SELECTA BIOSCIENCE ... | Myers Scott Dunseth | Director | Option Exercise | A | 4.01 | 40,000 | 160,400 | 40,000 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Myers Scott Dunseth | President & CEO | Option Exercise | D | 0.00 | 1,000,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Myers Scott Dunseth | President & CEO | Option Exercise | D | 0.00 | 1,000,000 | 0 | 0 | |
| Jun 23 2020 | SELB | SELECTA BIOSCIENCE ... | Myers Scott Dunseth | Director | Option Exercise | A | 3.00 | 20,000 | 60,000 | 20,000 | |
| Jun 23 2020 | SELB | SELECTA BIOSCIENCE ... | Myers Scott Dunseth | Director | Option Exercise | A | 3.00 | 20,000 | 60,000 | 20,000 | |
| Jun 01 2020 | HARP | Harpoon Therapeuti ... | Myers Scott Dunseth | Director | Option Exercise | A | 20.59 | 10,167 | 209,339 | 10,167 | |
| Apr 30 2020 | AVM | AMAG PHARMACEUTICA ... | Myers Scott Dunseth | President & CEO | Option Exercise | A | 8.20 | 1,000,000 | 8,200,000 | 1,000,000 | |
| Dec 26 2019 | SELB | SELECTA BIOSCIENCE ... | Myers Scott Dunseth | Director | Option Exercise | A | 1.46 | 19,704 | 28,768 | 19,704 | |
| Dec 26 2019 | SELB | SELECTA BIOSCIENCE ... | Myers Scott Dunseth | Director | Grant | A | 1.46 | 39,409 | 57,537 | 80,845 | 41.4 K to 80.8 K (+95.11 %) |
| Aug 20 2019 | SELB | SELECTA BIOSCIENCE ... | Myers Scott Dunseth | Director | Grant | A | 1.81 | 41,436 | 74,999 | 41,436 | 0 to 41.4 K |
| Jun 18 2019 | SELB | SELECTA BIOSCIENCE ... | Myers Scott Dunseth | Director | Option Exercise | A | 2.10 | 20,000 | 42,000 | 20,000 | |
| Jun 05 2019 | HARP | Harpoon Therapeuti ... | Myers Scott Dunseth | Director | Option Exercise | A | 11.84 | 10,167 | 120,377 | 10,167 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | D | 0.00 | 250,000 | 0 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | D | 0.00 | 6,300 | 0 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | D | 0.00 | 15,500 | 0 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | D | 0.00 | 42,000 | 0 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | D | 3.99 | 60,000 | 239,400 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | D | 4.64 | 190,000 | 881,600 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | D | 7.08 | 474,810 | 3,361,655 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Sell | U | 0.00 | 56,787 | 0 | 0 | 56.8 K to 0 (-100.00 %) |
| Feb 02 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | A | 0.00 | 250,000 | 0 | 250,000 | |
| Jan 16 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | M | 0.00 | 10,500 | 0 | 31,500 | |
| Jan 16 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Payment of Exercise | F | 3.92 | 3,429 | 13,442 | 56,787 | 60.2 K to 56.8 K (-5.69 %) |
| Jan 16 2018 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Buy | M | 0.00 | 10,500 | 0 | 60,216 | 49.7 K to 60.2 K (+21.12 %) |
| Nov 13 2017 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | A | 0.00 | 6,300 | 0 | 6,300 | |
| Sep 20 2017 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | A | 0.00 | 15,500 | 0 | 15,500 | |
| Sep 20 2017 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | A | 3.99 | 60,000 | 239,400 | 60,000 | |
| Aug 14 2017 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Buy | P | 3.74 | 5,500 | 20,543 | 49,716 | 44.2 K to 49.7 K (+12.44 %) |
| May 16 2017 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Buy | P | 4.00 | 2,800 | 11,192 | 44,216 | 41.4 K to 44.2 K (+6.76 %) |
| Apr 04 2017 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Buy | P | 4.11 | 2,000 | 8,229 | 41,416 | 39.4 K to 41.4 K (+5.07 %) |
| Mar 21 2017 | CASC | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Buy | P | 3.93 | 1,000 | 3,927 | 39,416 | 38.4 K to 39.4 K (+2.60 %) |
| Jan 31 2017 | ONTY | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Buy | P | 3.76 | 20,500 | 77,039 | 38,416 | 17.9 K to 38.4 K (+114.42 %) |
| Jan 13 2017 | ONTY | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | A | 0.00 | 42,000 | 0 | 42,000 | |
| Jan 13 2017 | ONTY | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Option Exercise | A | 4.64 | 190,000 | 881,600 | 190,000 | |
| Aug 18 2016 | ONTY | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Buy | P | 1.15 | 45,000 | 51,746 | 107,500 | 62.5 K to 107.5 K (+72.00 %) |
| Jun 28 2016 | ONTY | Cascadian Therapeu ... | Myers Scott Dunseth | President and CEO | Buy | P | 0.80 | 62,500 | 50,000 | 62,500 | 0 to 62.5 K |
| Apr 06 2016 | ONTY | Oncothyreon Inc. | Myers Scott Dunseth | President and CEO | Option Exercise | A | 1.18 | 2,848,855 | 3,361,649 | 2,848,855 | |
| May 26 2006 | DOVP | Euthymics Bioscien ... | Myers Scott Dunseth | Senior Vice Preside ... | Buy | P | 2.69 | 5,000 | 13,450 | 10,000 | 5 K to 10 K (+100.00 %) |
| May 26 2006 | DOVP | Euthymics Bioscien ... | Myers Scott Dunseth | Senior Vice Preside ... | Buy | P | 2.69 | 5,000 | 13,450 | 5,000 | 0 to 5 K |
Page: 1